These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35073963)

  • 1. Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson's disease: study protocol of a pilot add-on, randomised, controlled, pragmatic clinical trial.
    Yuen SCS; Chua KK; Zhong LLD; Chan KW; Chan CKH; Chan KL; Lin Z; Mok V; Lau AY; Li M
    Chin Med; 2022 Jan; 17(1):16. PubMed ID: 35073963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese medicine syndrome differentiation and treatment by stages of Parkinson's disease: study protocol for a multicentre, randomized, double-blind, placebo-controlled clinical trial.
    Hu Y; Gu S; Yuan X; Li H; Yuan C; Ye Q
    Chin Med; 2022 Jun; 17(1):68. PubMed ID: 35698234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial.
    Chaudhuri KR; Odin P; Ferreira JJ; Antonini A; Rascol O; Kurtis MM; Storch A; Bannister K; Soares-da-Silva P; Costa R; Magalhães D; Rocha JF
    BMC Neurol; 2022 Mar; 22(1):88. PubMed ID: 35279112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study.
    Carroll CB; Webb D; Stevens KN; Vickery J; Eyre V; Ball S; Wyse R; Webber M; Foggo A; Zajicek J; Whone A; Creanor S
    BMJ Open; 2019 Oct; 9(10):e029740. PubMed ID: 31594876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of acupuncture (Jin's three-needle) on motor symptoms and anxiety in patients with Parkinson's disease: protocol for a multicentre, randomised, assessor-blinded clinical trial.
    Liu X; Fan J; Leong II; Lu W; Zhang Y; Gong M; Zhuang L
    BMJ Open; 2024 Mar; 14(3):e081312. PubMed ID: 38548359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial.
    Chan KW; Ip TP; Kwong AS; Lui SL; Chan GC; Cowling BJ; Yiu WH; Wong DW; Liu Y; Feng Y; Tan KC; Chan LY; Leung JC; Lai KN; Tang SC
    BMJ Open; 2016 Aug; 6(8):e010741. PubMed ID: 27496229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial.
    Chan KW; Kwong ASK; Tsui PN; Cheung SCY; Chan GCW; Choi WF; Yiu WH; Zhang Y; Wong MM; Zhang ZJ; Tan KCB; Lao L; Tang SCW
    BMJ Open; 2021 Jan; 11(1):e042686. PubMed ID: 33436470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study protocol: randomised controlled hybrid type 2 trial evaluating the scale-up of two arts interventions for postnatal depression and Parkinson's disease.
    Soukup T; Davis RE; Baldellou Lopez M; Healey A; Estevao C; Fancourt D; Dazzan P; Pariante C; Dye H; Osborn T; Bind R; Sawyer K; Rebecchini L; Hazelgrove K; Burton A; Manoharan M; Perkins R; Podlewska A; Chaudhuri R; Derbyshire-Fox F; Hartley A; Woods A; Crane N; Bakolis I; Sevdalis N
    BMJ Open; 2022 Feb; 12(2):e055691. PubMed ID: 35105591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson's disease-A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol.
    Park MS; Park S; Kang JY; Jung IC; Yoo H
    PLoS One; 2024; 19(5):e0303156. PubMed ID: 38709746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese herbal medicine paratherapy for Parkinson's disease: a meta-analysis of 19 randomized controlled trials.
    Wang Y; Xie CL; Lu L; Fu DL; Zheng GQ
    Evid Based Complement Alternat Med; 2012; 2012():534861. PubMed ID: 23008740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.
    Ueno T; Kon T; Haga R; Nishijima H; Arai A; Tomiyama M
    Neurol Sci; 2020 Oct; 41(10):2867-2873. PubMed ID: 32328832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of yoga versus stretching and resistance training exercises on psychological distress for people with mild-to-moderate Parkinson's disease: study prxotocol for a randomized controlled trial.
    Kwok JYY; Kwan JCY; Auyeung M; Mok VCT; Chan HYL
    Trials; 2017 Nov; 18(1):509. PubMed ID: 29096672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxibustion treatment for Parkinson's disease: study protocol for a randomized controlled trial.
    Wu C; Zhao L; Guo Y; Hao X; Fan Y; Wu P; Han J; Li Q; Wang X; Wang Q; Luo X; Zhu M
    BMC Complement Med Ther; 2023 Jun; 23(1):193. PubMed ID: 37303044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM; Eyal E; Weintraub D;
    JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of herbal medicine Ukgansan for clinical symptoms in Parkinson's disease: A pilot, randomized, assessor-blinded clinical trial.
    Jin C; Cho KH; Kwon S; Lee HG; Kim TH; Jung WS; Moon SK; Cho SY; Kang BK; Park JM; Park HJ; Ko CN
    Front Neurol; 2022; 13():1025269. PubMed ID: 36438946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of Systematic Reviews of Chinese Herbal Medicine for Parkinson's Disease.
    Jin XC; Zhang L; Wang Y; Cai HB; Bao XJ; Jin YY; Zheng GQ
    Front Pharmacol; 2019; 10():155. PubMed ID: 30890935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial.
    Yao J; Jiao L; Yao Y; Lu Y; Shi J; Li J; Chen P; Xu L; Gong Y
    Trials; 2020 Apr; 21(1):309. PubMed ID: 32245480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of specialized nursing interventions for people with Parkinson's disease: the NICE-PD study protocol for a randomized controlled clinical trial.
    Radder DLM; Lennaerts HH; Vermeulen H; van Asseldonk T; Delnooz CCS; Hagen RH; Munneke M; Bloem BR; de Vries NM
    Trials; 2020 Jan; 21(1):88. PubMed ID: 31941538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel transcranial photobiomodulation device to address motor signs of Parkinson's disease: a parallel randomised feasibility study.
    Herkes G; McGee C; Liebert A; Bicknell B; Isaac V; Kiat H; McLachlan CS
    EClinicalMedicine; 2023 Dec; 66():102338. PubMed ID: 38094162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.